Decoding 6 Analyst Evaluations For Pacira BioSciences
Decoding 6 Analyst Evaluations For Pacira BioSciences
解讀6位分析師對pacira biosciences的評估
The standing of Pacira BioSciences...Across the recent three months, 6 analysts have shared their insights on Pacira BioSciences (NASDAQ:PCRX), expressing a variety of opinions spanning from bullish to bearish.
在最近三個月中，6位分析師對pacira biosciences（納斯達克:PCRX）分享了他們的看法，表達了從看好到看淡的各種意見。
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
下表提供了他們最近的評級快照，展示了情緒在過去30天中的演變情況，並將其與之前的月份進行比較。
The 12-month price targets, analyzed by analysts, offer insights with an average target of $21.17, a high estimate of $39.00, and a low estimate of $15.00. Highlighting a 2.31% decrease, the current average has fallen from the previous average price target of $21.67.
分析師分析的12個月價格目標提供了洞見，平均目標爲$21.17，最高估計爲$39.00，最低估計爲$15.00。當前平均值下降了2.31%，從之前的平均價格目標$21.67下降。
Understanding Analyst Ratings: A Comprehensive Breakdown
分析師評級：全面解析
The standing of Pacira BioSciences...
對paci...
登入免費觀看全文
登入/註冊
熱門討論
中概股財報季火熱：驚喜盈利能否延續漲勢？
1. 哪些行業可能成為本輪財報季的市場焦點？ 2. 在政府強調科技創新和可持續發展的背景下，你認為哪些行業具有最大的增長潜力？
Moomoo News Global
03/04 23:26
中國兩會：會議前後股票價格變動的關鍵要點